Exelixis, Inc.
Overview
Exelixis, Inc. is a biotechnology company committed to developing and commercializing innovative medicines that improve the care and outcomes of cancer patients. Headquartered in the United States, Exelixis is known for its robust pipeline of oncology-based therapeutics.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Exelixis, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Exelixis, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.